Glivclinic Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Other Publishers | Lessors of Real Estate | Real Estate Property Managers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction | Educational Support Services | Offices of Physicians | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals

Full name: Glivclinic Sp. z o.o.

Profile Updated: April 24, 2025

Glivclinic Sp. z o.o. is based in Poland. The head office is in Gliwice. It operates in the Ambulatory Health Care Services sector. It was first established on January 03, 2022. In its most recent financial highlights, the company reported a net sales revenue increase of 12.75% in 2025. Its’ total assets recorded a growth of 125.93%. Glivclinic Sp. z o.o.’s net profit margin decreased by 4.97% in 2025.

Headquarters
Ul. Ignacego Paderewskiego 10/2
Gliwice; Slaskie; Postal Code: 44-100

Contact Details: Purchase the Glivclinic Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Glivclinic Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Glivclinic Sp. z o.o. report to view the information.

Incorporation Date:

January 03, 2022

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

80%

Purchase this report to view the information.

20%

Company Performance

Financial values in the chart are available after Glivclinic Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

12.75%▲

Total Operating Revenue

12.92%▲

Operating Profit

-10.62%▼

EBITDA

-3.15%▼

Net Profit/Loss for the Period

-14.88%▼

Total Assets

125.93%▲

Total Equity

84.86%▲

Operating Profit Margin

-4.88%▼

Net Profit Margin

-4.97%▼

Return on Equity (ROE)

-53.79%▼

Debt / Equity

33.23%▲

Quick Ratio

-0.3%▼

Cash Ratio

0.07%▲

Similar companies

Related EMIS Industry Reports